Canaccord Genuity Group Forecasts Strong Price Appreciation for Insulet (NASDAQ:PODD) Stock
Insulet (NASDAQ:PODD – Get Free Report) had its target price upped by stock analysts at Canaccord Genuity Group from $304.00 to $324.00 in a report issued on Friday,Benzinga reports. The firm presently has a “buy” rating on the medical instruments supplier’s stock. Canaccord Genuity Group’s price objective points to a potential upside of 14.57% from […]
Insulet (NASDAQ:PODD – Get Free Report) had its target price upped by stock analysts at Canaccord Genuity Group from $304.00 to $324.00 in a report issued on Friday,Benzinga reports. The firm presently has a “buy” rating on the medical instruments supplier’s stock. Canaccord Genuity Group’s price objective points to a potential upside of 14.57% from […]
